{"header":{"type":"esummary","version":"0.3"},"result":{"uids":["18950853","23561987","23055539","34551989","42810372"],"18950853":{"uid":"18950853","pubdate":"2008 Nov 29","epubdate":"2008 Oct 22","source":"Lancet","authors":[{"name":"Astrup A","authtype":"Author","clusterid":""},{"name":"Madsbad S","authtype":"Author","clusterid":""},{"name":"Breum L","authtype":"Author","clusterid":""},{"name":"Jensen TJ","authtype":"Author","clusterid":""},{"name":"Kroustrup JP","authtype":"Author","clusterid":""},{"name":"Larsen TM","authtype":"Author","clusterid":""}],"lastauthor":"Larsen TM","title":"Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.","sorttitle":"effect of tesofensine on bodyweight loss body composition and quality of life in obese patients a randomised double blind placebo controlled trial","volume":"372","issue":"9653","pages":"1906-1913","lang":["eng"],"nlmuniqueid":"2985213R","issn":"0140-6736","essn":"1474-547X","pubtype":["Clinical Trial, Phase II","Journal Article","Multicenter Study","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"],"recordstatus":"PubMed - indexed for MEDLINE","pubstatus":"256","articleids":[{"idtype":"pubmed","idtypen":1,"value":"18950853"},{"idtype":"doi","idtypen":3,"value":"10.1016/S0140-6736(08)61525-1"},{"idtype":"pii","idtypen":4,"value":"S0140-6736(08)61525-1"}],"history":[{"pubstatus":"pubmed","date":"2008/10/28 09:00"},{"pubstatus":"medline","date":"2008/12/17 09:00"},{"pubstatus":"entrez","date":"2008/10/28 09:00"}],"references":[{"refsource":"Lancet. 2009 Feb 28;373(9665):719; author reply 720. doi: 10.1016/S0140-6736(09)60432-3.","reftype":"Comment in","pmid":19249625,"note":""},{"refsource":"Lancet. 2009 Feb 28;373(9665):719; author reply 720. doi: 10.1016/S0140-6736(09)60433-5.","reftype":"Comment in","pmid":19249626,"note":""},{"refsource":"Lancet. 2013 Apr 6;381(9873):1167. doi: 10.1016/S0140-6736(13)60778-3.","reftype":"Comment in","pmid":23561987,"note":""},{"refsource":"Lancet. 2013 Apr 6;381(9873):1167. doi: 10.1016/S0140-6736(13)60778-3.","reftype":"Expression of concern in","pmid":23561987,"note":""}],"attributes":["Has Abstract"],"pmcrefcount":"","fulljournalname":"Lancet (London, England)","elocationid":"doi: 10.1016/S0140-6736(08)61525-1","doctype":"citation","srccontriblist":[],"booktitle":"","medium":"","edition":"","publisherlocation":"","publishername":"","srcdate":"","reportnumber":"","availablefromurl":"","locationlabel":"","doccontriblist":[],"docdate":"","bookname":"","chapter":"","sortpubdate":"2008/11/29 00:00","sortfirstauthor":"Astrup A","vernaculartitle":""},"23561987":{"uid":"23561987","pubdate":"2013 Apr 6","epubdate":"","source":"Lancet","authors":[],"lastauthor":"","title":"Expression of concern--effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.","sorttitle":"expression of concern effect of tesofensine on bodyweight loss body composition and quality of life in obese patients a randomised double blind placebo controlled trial","volume":"381","issue":"9873","pages":"1167","lang":["eng"],"nlmuniqueid":"2985213R","issn":"0140-6736","essn":"1474-547X","pubtype":["Editorial","Comment","Expression of Concern"],"recordstatus":"PubMed","pubstatus":"4","articleids":[{"idtype":"pubmed","idtypen":1,"value":"23561987"},{"idtype":"doi","idtypen":3,"value":"10.1016/S0140-6736(13)60778-3"},{"idtype":"pii","idtypen":4,"value":"S0140-6736(13)60778-3"}],"history":[{"pubstatus":"entrez","date":"2013/04/09 06:00"},{"pubstatus":"pubmed","date":"2013/04/09 06:00"},{"pubstatus":"medline","date":"2013/04/20 06:00"}],"references":[{"refsource":"Lancet. 2008 Nov 29;372(9653):1906-1913. doi: 10.1016/S0140-6736(08)61525-1.","reftype":"Comment on","pmid":18950853,"note":""},{"refsource":"Lancet. 2008 Nov 29;372(9653):1906-1913. doi: 10.1016/S0140-6736(08)61525-1.","reftype":"Expression of concern for","pmid":18950853,"note":""},{"refsource":"Lancet. 2013 Jul 13;382(9887):127. doi: 10.1016/S0140-6736(13)61563-9.","reftype":"Comment in","pmid":23849924,"note":""}],"attributes":[],"pmcrefcount":"","fulljournalname":"Lancet (London, England)","elocationid":"doi: 10.1016/S0140-6736(13)60778-3","doctype":"citation","srccontriblist":[],"booktitle":"","medium":"","edition":"","publisherlocation":"","publishername":"","srcdate":"","reportnumber":"","availablefromurl":"","locationlabel":"","doccontriblist":[],"docdate":"","bookname":"","chapter":"","sortpubdate":"2013/04/06 00:00","sortfirstauthor":"","vernaculartitle":""},"23055539":{"uid":"23055539","pubdate":"2013 Jan","epubdate":"2012 Oct 10","source":"J Pharmacol Exp Ther","authors":[{"name":"McCoy AT","authtype":"Author","clusterid":""},{"name":"Benoist CC","authtype":"Author","clusterid":""},{"name":"Wright JW","authtype":"Author","clusterid":""},{"name":"Kawas LH","authtype":"Author","clusterid":""},{"name":"Bule-Ghogare JM","authtype":"Author","clusterid":""},{"name":"Zhu M","authtype":"Author","clusterid":""},{"name":"Appleyard SM","authtype":"Author","clusterid":""},{"name":"Wayman GA","authtype":"Author","clusterid":""},{"name":"Harding JW","authtype":"Author","clusterid":""}],"lastauthor":"Harding JW","title":"Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.","sorttitle":"evaluation of metabolically stabilized angiotensin iv analogs as procognitive antidementia agents","volume":"344","issue":"1","pages":"141-54","lang":["eng"],"nlmuniqueid":"0376362","issn":"0022-3565","essn":"1521-0103","pubtype":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"recordstatus":"PubMed - indexed for MEDLINE","pubstatus":"256","articleids":[{"idtype":"pubmed","idtypen":1,"value":"23055539"},{"idtype":"pmc","idtypen":8,"value":"PMC3533412"},{"idtype":"pmcid","idtypen":5,"value":"pmc-id: PMC3533412;"},{"idtype":"doi","idtypen":3,"value":"10.1124/jpet.112.199497"},{"idtype":"pii","idtypen":4,"value":"S0022-3565(24)18473-X"}],"history":[{"pubstatus":"entrez","date":"2012/10/12 06:00"},{"pubstatus":"pubmed","date":"2012/10/12 06:00"},{"pubstatus":"medline","date":"2013/02/27 06:00"},{"pubstatus":"pmc-release","date":"2014/01/01 00:00"}],"references":[{"refsource":"J Pharmacol Exp Ther. 2021 Sep;378(3):313. doi: 10.1124/jpet.112.199497concern.","reftype":"Expression of concern in","pmid":34551989,"note":""}],"attributes":["Has Abstract"],"pmcrefcount":43,"fulljournalname":"The Journal of pharmacology and experimental therapeutics","elocationid":"doi: 10.1124/jpet.112.199497","doctype":"citation","srccontriblist":[],"booktitle":"","medium":"","edition":"","publisherlocation":"","publishername":"","srcdate":"","reportnumber":"","availablefromurl":"","locationlabel":"","doccontriblist":[],"docdate":"","bookname":"","chapter":"","sortpubdate":"2013/01/01 00:00","sortfirstauthor":"McCoy AT","vernaculartitle":""},"34551989":{"uid":"34551989","pubdate":"2021 Sep","epubdate":"","source":"J Pharmacol Exp Ther","authors":[],"lastauthor":"","title":"Notice of Concern: McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2013) Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents, J Pharmacol Exp Ther, 344: 141-154; DOI: https://doi.org/10.1124/jpet.112.199497.","sorttitle":"notice of concern mccoy at benoist cc wright jw kawas lh bule ghogare jm zhu m appleyard sm wayman ga and harding jw 2013 evaluation of metabolically stabilized angiotensin iv analogs as procognitive antidementia agents j pharmacol exp ther 344 141 154 doi https doi org 10 1124 jpet 112 199497","volume":"378","issue":"3","pages":"313","lang":["eng"],"nlmuniqueid":"0376362","issn":"0022-3565","essn":"1521-0103","pubtype":["Journal Article","Expression of Concern"],"recordstatus":"PubMed","pubstatus":"4","articleids":[{"idtype":"pubmed","idtypen":1,"value":"34551989"},{"idtype":"doi","idtypen":3,"value":"10.1124/jpet.112.199497concern"},{"idtype":"pii","idtypen":4,"value":"S0022-3565(24)25718-9"}],"history":[{"pubstatus":"entrez","date":"2021/09/23 05:57"},{"pubstatus":"pubmed","date":"2021/09/24 06:00"},{"pubstatus":"medline","date":"2021/09/24 06:01"}],"references":[{"refsource":"J Pharmacol Exp Ther. 2013 Jan;344(1):141-54. doi: 10.1124/jpet.112.199497.","reftype":"Expression of concern for","pmid":23055539,"note":""}],"attributes":[],"pmcrefcount":"","fulljournalname":"The Journal of pharmacology and experimental therapeutics","elocationid":"doi: 10.1124/jpet.112.199497concern","doctype":"citation","srccontriblist":[],"booktitle":"","medium":"","edition":"","publisherlocation":"","publishername":"","srcdate":"","reportnumber":"","availablefromurl":"","locationlabel":"","doccontriblist":[],"docdate":"","bookname":"","chapter":"","sortpubdate":"2021/09/01 00:00","sortfirstauthor":"","vernaculartitle":""},"42810372":{"uid":"42810372","pubdate":"2026 Sep 29","epubdate":"2026 Sep 29","source":"Lancet","authors":[{"name":"Bellido V","authtype":"Author","clusterid":""},{"name":"le Roux CW","authtype":"Author","clusterid":""},{"name":"Ekinci EI","authtype":"Author","clusterid":""},{"name":"Bjornstad P","authtype":"Author","clusterid":""},{"name":"Frias JP","authtype":"Author","clusterid":""},{"name":"Giblin K","authtype":"Author","clusterid":""},{"name":"Eyde S","authtype":"Author","clusterid":""},{"name":"Park SY","authtype":"Author","clusterid":""},{"name":"Ferro J","authtype":"Author","clusterid":""},{"name":"Johnson C","authtype":"Author","clusterid":""},{"name":"Taylor A","authtype":"Author","clusterid":""}],"lastauthor":"Taylor A","title":"Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.","sorttitle":"retatrutide in adults with obesity and type 2 diabetes triumph 2 a double blind parallel group randomised placebo controlled phase 3 trial","volume":"","issue":"","pages":"","lang":["eng"],"nlmuniqueid":"2985213R","issn":"0140-6736","essn":"1474-547X","pubtype":["Journal Article"],"recordstatus":"PubMed - as supplied by publisher","pubstatus":"10","articleids":[{"idtype":"pubmed","idtypen":1,"value":"42810372"},{"idtype":"doi","idtypen":3,"value":"10.1016/S0140-6736(26)01861-1"},{"idtype":"pii","idtypen":4,"value":"S0140-6736(26)01861-1"}],"history":[{"pubstatus":"received","date":"2026/08/18 00:00"},{"pubstatus":"revised","date":"2026/09/04 00:00"},{"pubstatus":"accepted","date":"2026/09/08 00:00"},{"pubstatus":"medline","date":"2026/09/29 23:29"},{"pubstatus":"pubmed","date":"2026/09/29 23:29"},{"pubstatus":"entrez","date":"2026/09/29 18:54"}],"references":[],"attributes":["Has Abstract"],"pmcrefcount":"","fulljournalname":"Lancet (London, England)","elocationid":"pii: S0140-6736(26)01861-1. doi: 10.1016/S0140-6736(26)01861-1","doctype":"citation","srccontriblist":[],"booktitle":"","medium":"","edition":"","publisherlocation":"","publishername":"","srcdate":"","reportnumber":"","availablefromurl":"","locationlabel":"","doccontriblist":[],"docdate":"","bookname":"","chapter":"","sortpubdate":"2026/09/29 00:00","sortfirstauthor":"Bellido V","vernaculartitle":""}}}